Most in vitro models rely on iPSC-derived neurons that resemble embryonic stages, limiting their ability to reproduce late-onset disease features.
Our platform generates age-defined human neurons that preserve disease-relevant characteristics, enabling more predictive and translational research.

Why Age Matters in Neurodegeneration Models

Product-Cited Publications

MN203 – Human Motor Neurons

Immunity | 2026

Used to investigate microglia-driven neuroinflammation and TDP-43 pathology in neurodegenerative disease models

✚Customer-Cited

Conducted by a U.S. National Academy of Sciences member–led research team

DN101, DN601 – Human Dopaminergic Neurons

Biotechnology Journal | 2023

Used for immunoblotting analysis of age-associated protein signatures in dopaminergic neuron models

✚Application Study

BFCN601, BFCNAD04 – Human Basal Forebrain Cholinergic Neurons

bioRxiv | 2024

Used to evaluate the efficacy of FDA-approved lecanemab in Alzheimer's disease–relevant models

✚Drug Validation Study

Additional product-cited publications forthcoming
Access human neuronal models that recapitulate key pathological features of neurodegenerative diseases.

Disease Models

Subtype-specific human neurons generated through Efficient Cell Conversion Technology (ECT)
Preserve aging and disease signatures to recapitulate pathology and enable translational drug discovery

Human Neuronal Cell Solutions

Drug Discovery & Screening · Disease Mechanism Research · Toxicity & Safety Evaluation

Applications

Go Beyond Embryonic Models
A platform designed to preserve aging biology and capture true disease pathology in human neurons

Our Technology

News

Start Your Project with Us

Looking to build more predictive models for neurodegenerative diseases? Our team is ready to support your research and drug discovery programs.

Name:
Tel:
Email:
Company:
Message Content:
CAPTCHA